Drug Database
Back to search

Canada· CA-DIN-02262568

ACID CONCENTRATE A1269

A hemodialytics, concentrates product containing magnesium chloride + dextrose + potassium chloride + sodium chloride, registered in Canada by CHIEF MEDICAL SUPPLIES LTD. The same ATC class is registered in 2 of our 19 countries.

ATC B05ZA

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedACID CONCENTRATE A1269ATCB05ZAREGISTER NO.CA-DIN-02262568PACKS LISTED0CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about magnesium chloride + dextrose + potassium chloride + sodium chlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Magnesium chloride + dextrose + potassium chloride + sodium chloride is registered in 2 of 19 countries.

Countries holding a registration under ATC B05ZA (hemodialytics, concentrates), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 1 of them publish a price we can compare per daily dose
Search magnesium chloride + dextrose + potassium chloride + sodium chloride products by name

Magnesium chloride + dextrose + potassium chloride + sodium chloride · ATC B05ZA

2 / 19 countries

  • Canada
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
MAGNESIUM CHLORIDE + DEXTROSE + POTASSIUM CHLORIDE + SODIUM CHLORIDE
Manufacturer
CHIEF MEDICAL SUPPLIES LTD
Country
Canada (CA)
ATC code
B05ZA
ATC class
Hemodialytics, concentrates
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Magnesium chloride + dextrose + potassium chloride + sodium chloride in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All magnesium chloride + dextrose + potassium chloride + sodium chloride products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Belgium · Plasmalyte 148, Plasmalyte 148 Viaflo
  • Bulgaria · Гнак
  • Cyprus · Maintelyte, Plasmalyte + Glucose 5%
  • Czechia · Gnak, Plasmalyte S Glukózou
  • Germany · Maintelyte
  • Denmark · Glucose-Na-K Baxter, Plasmalyte
  • Spain · Maintelyte, Viaflo Plasmalyte 148 Y Glucosa
  • Finland · Glucose-Na-K Baxter, Plasmalyte Glucos
  • France · Maintelyte, Plasmalyte Et Glucose
  • United Kingdom (Northern Ireland) · Maintelyte, Plasma-Lyte 148
  • Greece · Maintelyte, Plasmalyte + Glucose 5%
  • Croatia · Gnak, Plasmalyte + Glucose
  • Ireland · Maintelyte, Plasma-Lyte 148 & Glucose
  • Iceland · Plasmalyte Glucos
  • Italy · Crystalglu, Elettrolitica Bilanciata Di Mantenimento Con Glucosio Fresenius Kabi Italia
  • Luxembourg · Plasmalyte 148 + Glucose Viaflo, Plasmalyte 148 Viaflo
  • Malta · Maintelyte, Plasma-Lyte 148 & Glucose
  • Netherlands · Maintelyte, Plasma-Lyte 148 + Glucose
  • Norway · Glucose-Na-K Baxter, Karbolytt
  • Poland · Gnak
  • Portugal · Maintelyte, Plasma-Lyte 148 E Glucose Viaflo
  • Romania · Gnak
  • Sweden · Glucose-Na-K Baxter, Plasmalyte Glucos
  • Slovenia · Gnak, Plasmalyte Z Glukozo
  • Slovakia · Gnak, Plasmalyte + Glucose 5%

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/df812a96-7141-4667-be8d-e5dc3288f7b6
GET /v1/drugs/df812a96-7141-4667-be8d-e5dc3288f7b6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02262568",
  "form": "SOLUTION",
  "class": "Human",
  "routes": [
    "HAEMODIALYSIS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "B05ZA",
  "schedule": [
    "Ethical"
  ],
  "drug_code": "74794",
  "strengths": [
    "4.57 G",
    "74.25 G",
    "6.71 G",
    "263 G",
    "10.81 G",
    "6.62 G"
  ],
  "ahfs_class": null,
  "substances": [
    "MAGNESIUM CHLORIDE",
    "DEXTROSE",
    "POTASSIUM CHLORIDE",
    "SODIUM CHLORIDE",
    "ACETIC ACID",
    "CALCIUM CHLORIDE"
  ],
  "product_categorization": null
}
API referenceMCP serverPlans

See everything about magnesium chloride + dextrose + potassium chloride + sodium chloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console